Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Illumina Advises Stockholders To Take No Action In Response To Roche's New Offer

RELATED NEWS
Trade ILMN now with 

Illumina, Inc. (ILMN: Quote) suggested that its stockholders take no action at this time in response to announcement by Roche Holding AG (RHHBY.PK) that it is now offering to acquire Illumina for $51.00 per share in cash.

Earlier, on February 7, 2012, Illumina's Board of Directors rejected Roche's $44.50 per share cash tender offer and recommended that stockholders not tender their shares.

Illumina stated that its Board of Directors will thoroughly review Roche's revised proposal and make a recommendation to stockholders regarding the proposal in due course.

Click here to receive FREE breaking news email alerts for Illumina Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Eurozone manufacturing moved closer to stagnation in September as German factory sector contracted for the first time in 15 months, final data from Markit Economics showed Wednesday. The manufacturing Purchasing Managers' Index fell more than intially estimated to a 14-month low of 50.3 from August's reading 50.7. The reading was below the earlier flash estimate of 50.5. Indonesia's inflation accelerated in September on food and utility costs, data from the Central Statistics Agency showed Wednesday. The trade balance swung into deficit in August as import growth exceeded the increase in exports. Inflation rose to 4.53 percent in September from 3.99 percent in... The U.K. economy grew more than estimated in the second quarter and the current account deficit widened from the first quarter, the Office for National Statistics said Tuesday. Gross domestic product grew 0.9 percent sequentially, up from the prior estimate of 0.8 percent. The annual growth was confirmed at 3.2 percent.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.